Diabetes and coronary artery disease - Therapy and outcomes

Coronary Artery Disease

Volumn 12, Issue 2, 2001, Pages 149-152

  Rutherford, John D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROLASE; INSULIN; LISINOPRIL; LOW DENSITY LIPOPROTEIN; RAMIPRIL; TRANDOLAPRIL;

ACUTE HEART INFARCTION; AGE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DIABETES MELLITUS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RESTENOSIS; REVIEW; SURVIVAL; TREATMENT OUTCOME;

CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS;

EID: 0035100318     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200103000-00009     Document Type: Review

References (39)

1. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida
2. Diabetes mellitus: A major risk factor for cardiovascular disease
3. Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction
4. Prognosis in diabetics in whom the initial suspicion of acute myocardial infarction was not confirmed
5. Outcome of unstable angina in patients with diabetes mellitus
6. Impact of diabetes on mortality after the first myocardial infarction
7. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects
8. Retinopathy predicts coronary heart disease events in NIDDM patients
9. Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients
10. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease
11. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomised trials of more than 1000 patients
12. Withholding thrombolysis in patients with diabetes mellitus and acute myocardial infarction
13. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries
14. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
15. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction
16. Mortality prediction in diabetic patients with myocardial infarction: Experiences from the DIGAMI study
17. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
18. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study
19. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study
20. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
21. Diabetes Atherosclerosis Intervention Study (DAIS) Results
22. The Diabetes Atherosolerosis Intervention Study (DAIS): A study conducted in cooperation with the World Health Organization
23. Baseline characteristics of the study population in the Diabetes Atherosolerosis Intervention Study (DAIS). World Health Organization Collaborating Centre for the Study of Atherosolerosis in Diabetes
24. The cost-effectiveness of lipid lowering in patients with diabetes: Results from the 4S trial
25. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study
26. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction
27. Effects of an Angiotensin-Converting-Enzyme inhibitor Ramipril,on cardiovascular events in high-risk patients
28. β-blockers and sudden cardiac death
29. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the national cooperative cardiovascular project
30. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
31. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
32. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
33. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy
34. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
35. Coronary revascularization in diabetic patients. A comparison of the randomized and observational components of the bypass angioplasty revascularization investigation (BARI)
36. Influence of Diabetes on 5-year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients with Multivessel Disease
37. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
38. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty
39. Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial